Cart
sales@molnova.com
XEN-402
CAS No. 1259933-16-8
XEN-402( Funapide | TV-45070 )
Catalog No. M11070 CAS No. 1259933-16-8
XEN-402 (Funapide;TV-45070) is a potent and selective, orally available sodium channel Nav1.7 and Nav1.8 blocker for treatment of pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 357 | Get Quote |
|
| 10MG | 530 | Get Quote |
|
| 25MG | 851 | Get Quote |
|
| 50MG | 1152 | Get Quote |
|
| 100MG | 1557 | Get Quote |
|
| 500MG | 3114 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameXEN-402
-
NoteResearch use only, not for human use.
-
Brief DescriptionXEN-402 (Funapide;TV-45070) is a potent and selective, orally available sodium channel Nav1.7 and Nav1.8 blocker for treatment of pain.
-
DescriptionXEN-402 (Funapide;TV-45070) is a potent and selective, orally available sodium channel Nav1.7 and Nav1.8 blocker for treatment of pain. Pain Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsFunapide | TV-45070
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number1259933-16-8
-
Formula Weight429.35
-
Molecular FormulaC22H14F3NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 200 mg/mL (465.82 mM)
-
SMILESO=C([C@]12COC3=C1C=C(OCO4)C4=C3)N(CC5=CC=C(C(F)(F)F)O5)C6=C2C=CC=C6
-
Chemical Name(3'S)-1'-{[5-(trifluoromethyl)furan-2-yl]methyl}-2H,6H-spiro[furo[2,3-f][1,3]benzodioxole-7,3'-indol]-2'(1'H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bagal SK, et al. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3690-9.
2. Goldberg YP, et al. Pain. 2012 Jan;153(1):80-5.
molnova catalog
related products
-
Eleclazine hydrochlo...
A novel, potent, and selective inhibitor of Late sodium current (late INa) for treatment of long QT-3 syndrome (LQT-3).
-
Pramoxine hydrochlor...
Pramocaine hydrochloride is a topical anesthetic, and used as an antipruritic.
-
Huwentoxin IV
Selective NaV1.7 channel blocker. Preferentially inhibits neuronal NaV1.7, 1.2 and 1.3 (IC50 values are 26, 150 and 338 nM respectively), compared to muscle subtypes NaV1.4 and 1.5 (IC50 = >10 μM). Inhibits the channel by binding at the neurotoxin receptor site 4 in the S3-S4 linker of domain II, trapping the voltage sensor in the inward, closed configuration.
